JOURNAL ARTICLE

Does Tennessee's Ban on Puberty Blockers and Hormone Therapy to Facilitate a Minor's Sex Transition Violate the Equal Protection Clause?

  • Published In: Preview of United States Supreme Court Cases, 2024, v. 52, n. 3. P. 15 1 of 3

  • Database: Criminal Justice Abstracts with Full Text 2 of 3

  • Authored By: Schwinn, Steven D. 3 of 3

Abstract

In March 2023, Tennessee adopted a law that prohibits health-care providers from delivering puberty blockers and hormone therapy to transgender minors to facilitate their transition to another sex. At the same time, the law specifically allows health-care providers to deliver puberty blockers and hormone therapy to treat a minor’s congenital defect, precocious puberty, or other conditions. Tennessee contends that the law advances its interests in the health and safety of minors in the state and in protecting the integrity and ethics of the medical profession. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Preview of United States Supreme Court Cases. 2024/12, Vol. 52, Issue 3, p15
  • Document Type:Article
  • Subject Area:Law
  • Publication Date:2024
  • ISSN:0363-0048
  • Accession Number:182371429
  • Copyright Statement:Copyright of Preview of United States Supreme Court Cases is the property of American Bar Association and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.